Zydus Q1: Novel Molecule Enters Phase I, Global Biosimilar Strategy To Shift?

Indian Firm Looking Forward To 505(b)(2) Sitagliptin Contribution

 
• By Vibha Ravi
  
Business growth
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business